Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Andrew D Hislop

Showing results (31-40 of 46) with videos related to

Pageof 5
Sort By:
Blood|July 21, 2010
Impaired Epstein-Barr virus-specific CD8+ T-cell function in X-linked lymphoproliferative disease is restricted to SLAM family-positive B-cell targetsAndrew D Hislop, Umaimainthan Palendira, Alison M Leese, et al.
Journal of Virology|April 12, 2012
Suppression of antigen-specific T cell responses by the Kaposi's sarcoma-associated herpesvirus viral OX2 protein and its cellular orthologue, CD200Karen Misstear, Simon A Chanas, S A Rahim Rezaee, et al.
Blood|July 19, 2008
Selective accumulation of virus-specific CD8+ T cells with unique homing phenotype within the human bone marrowUmaimainthan Palendira, Rosanna Chinn, Wajid Raza, et al.
The Journal of Experimental Medicine|July 11, 2007
A CD8+ T cell immune evasion protein specific to Epstein-Barr virus and its close relatives in Old World primatesAndrew D Hislop, Maaike E Ressing, Daphne van Leeuwen, et al.
Plos Pathogens|June 27, 2009
Stage-specific inhibition of MHC class I presentation by the Epstein-Barr virus BNLF2a protein during virus lytic cycleNathan P Croft, Claire Shannon-Lowe, Andrew I Bell, et al.
Blood|July 20, 2002
Epstein-Barr virus-specific CD8(+) T cells that re-express CD45RA are apoptosis-resistant memory cells that retain replicative potentialPadraic J Dunne, Jeffery M Faint, Nancy H Gudgeon, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|May 18, 2006
Management of Epstein-Barr virus (EBV) reactivation after allogeneic stem cell transplantation by simultaneous analysis of EBV DNA load and EBV-specific T cell reconstitutionNicola E Annels, Jayant S Kalpoe, Robbert G M Bredius, et al.
The Journal of Clinical Investigation|August 20, 2005
Tonsillar homing of Epstein-Barr virus-specific CD8+ T cells and the virus-host balanceAndrew D Hislop, Michael Kuo, Adrian B Drake-Lee, et al.
Journal of Immunology (Baltimore, Md. : 1950)|February 8, 2011
EBV protein BNLF2a exploits host tail-anchored protein integration machinery to inhibit TAPDaniëlle Horst, Vincenzo Favaloro, Fabio Vilardi, et al.
Blood|August 15, 2002
B cells immortalized by a mini-Epstein-Barr virus encoding a foreign antigen efficiently reactivate specific cytotoxic T cellsAndreas Moosmann, Naeem Khan, Mark Cobbold, et al.
Pageof 5

Showing results (31-40 of 46) with videos related to

Sort By:
Pageof 5
Blood|July 21, 2010
Impaired Epstein-Barr virus-specific CD8+ T-cell function in X-linked lymphoproliferative disease is restricted to SLAM family-positive B-cell targetsAndrew D Hislop, Umaimainthan Palendira, Alison M Leese, et al.
Journal of Virology|April 12, 2012
Suppression of antigen-specific T cell responses by the Kaposi's sarcoma-associated herpesvirus viral OX2 protein and its cellular orthologue, CD200Karen Misstear, Simon A Chanas, S A Rahim Rezaee, et al.
Blood|July 19, 2008
Selective accumulation of virus-specific CD8+ T cells with unique homing phenotype within the human bone marrowUmaimainthan Palendira, Rosanna Chinn, Wajid Raza, et al.
The Journal of Experimental Medicine|July 11, 2007
A CD8+ T cell immune evasion protein specific to Epstein-Barr virus and its close relatives in Old World primatesAndrew D Hislop, Maaike E Ressing, Daphne van Leeuwen, et al.
Plos Pathogens|June 27, 2009
Stage-specific inhibition of MHC class I presentation by the Epstein-Barr virus BNLF2a protein during virus lytic cycleNathan P Croft, Claire Shannon-Lowe, Andrew I Bell, et al.
Blood|July 20, 2002
Epstein-Barr virus-specific CD8(+) T cells that re-express CD45RA are apoptosis-resistant memory cells that retain replicative potentialPadraic J Dunne, Jeffery M Faint, Nancy H Gudgeon, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|May 18, 2006
Management of Epstein-Barr virus (EBV) reactivation after allogeneic stem cell transplantation by simultaneous analysis of EBV DNA load and EBV-specific T cell reconstitutionNicola E Annels, Jayant S Kalpoe, Robbert G M Bredius, et al.
The Journal of Clinical Investigation|August 20, 2005
Tonsillar homing of Epstein-Barr virus-specific CD8+ T cells and the virus-host balanceAndrew D Hislop, Michael Kuo, Adrian B Drake-Lee, et al.
Journal of Immunology (Baltimore, Md. : 1950)|February 8, 2011
EBV protein BNLF2a exploits host tail-anchored protein integration machinery to inhibit TAPDaniëlle Horst, Vincenzo Favaloro, Fabio Vilardi, et al.
Blood|August 15, 2002
B cells immortalized by a mini-Epstein-Barr virus encoding a foreign antigen efficiently reactivate specific cytotoxic T cellsAndreas Moosmann, Naeem Khan, Mark Cobbold, et al.
Pageof 5